These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 21619384)

  • 1. Neointimal hyperplasia inhibition effect of angiotensin II type 1 receptor blockers in patients after coronary stent implantation: a meta-analysis.
    Kun X; Yong L; Bo J; Hai-Ming S
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):209-13. PubMed ID: 21619384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventing effect of angiotensin II receptor blocker on neointimal hyperplasia after vascular injury].
    Miyata M; Eto H; Biro S; Tei C
    Nihon Rinsho; 2002 Oct; 60(10):1957-61. PubMed ID: 12397691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation.
    Groenewegen HC; van der Harst P; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
    Int J Cardiol; 2008 May; 126(2):209-15. PubMed ID: 17482691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease.
    Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW
    Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plaque debulking before stent implantation on in-stent neointimal proliferation: a serial 3-dimensional intravascular ultrasound study.
    Takeda Y; Tsuchikane E; Kobayashi T; Terai K; Kobayashi Y; Nakagawa T; Sakurai M; Awata N; Kobayashi T
    Am Heart J; 2003 Jul; 146(1):175-82. PubMed ID: 12851628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits.
    Ichikawa N; Toma N; Kawakita F; Matsushima S; Imanaka-Yoshida K; Yoshida T; Taki W; Suzuki HI
    Neurol Res; 2015 Feb; 37(2):147-52. PubMed ID: 25089806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neointima hyperplasia and alteration of angiotensin II AT1 receptors after coronary stent implantation].
    Li G; Lin SG; Chen JY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):96-8, 108. PubMed ID: 15684010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockade in the prevention of in-stent restenosis: systemic versus local delivery.
    Celik T; Iyisoy A; Jata B; Celik M; Isik E
    Int J Cardiol; 2009 May; 134(2):249-50. PubMed ID: 18207259
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-eluting stents: clinical experiences and perspectives.
    Grube E; Gerckens U; Buellesfeld L
    Minerva Cardioangiol; 2002 Oct; 50(5):469-73. PubMed ID: 12384629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial.
    Peters S; Trümmel M; Meyners W; Koehler B; Westermann K
    Int J Cardiol; 2005 Feb; 98(2):331-5. PubMed ID: 15686787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.